ABSTRACT
PURPOSE: This research examined road traffic injury mortality and morbidity disparities across of country development status, and discussed the possibility of reducing country disparities by various actions to accelerate the pace of achieving Sustainable Development Goals target 3.6 - to halve the number of global deaths and injuries from road traffic accidents by 2020. METHODS: Data for road traffic mortality, morbidity, and socio-demographic index (SDI) were extracted by country from the estimates of the Global Burden of Disease study, and the implementation of the three types of national actions (legislation, prioritized vehicle safety standards, and trauma-related post-crash care service) were extracted from the Global Status Report on Road Safety by World Health Organization. We fitted joinpoint regression analysis to identify and quantify the significant rate changes from 2011 to 2017. RESULTS: Age-adjusted road traffic mortality decreased substantially for all the five SDI categories from 2011 to 2017 (by 7.52%-16.08%). Age-adjusted road traffic mortality decreased significantly as SDI increased in the study time period, while age-adjusted morbidity generally increased as SDI increased. Subgroup analysis by road user yielded similar results, but with two major differences during the study period of 2011 to 2017: (1) pedestrians in the high SDI countries experienced the lowest mortality (1.68-1.90 per 100,000 population) and morbidity (110.45-112.72 per 100,000 population for incidence and 487.48-491.24 per 100,000 population for prevalence), and (2) motor vehicle occupants in the high SDI countries had the lowest mortality (4.07-4.50 per 100,000 population) but the highest morbidity (428.74-467.78 per 100,000 population for incidence and 1025.70-1116.60 per 100,000 population for prevalence). Implementation of the three types of national actions remained nearly unchanged in all five SDI categories from 2011 to 2017 and was consistently stronger in the higher SDI countries than in the lower SDI countries. Lower income nations comprise the heaviest burden of global road traffic injuries and deaths. CONCLUSION: Global road traffic deaths would decrease substantially if the large mortality disparities across country development status were reduced through full implementation of proven national actions including legislation and law enforcement, prioritized vehicle safety standards and trauma-related post-crash care services.
Subject(s)
Accidental Injuries/epidemiology , Accidental Injuries/mortality , Accidents, Traffic/statistics & numerical data , Developing Countries/statistics & numerical data , Pedestrians/statistics & numerical data , Sustainable Development , Accidental Injuries/prevention & control , Accidents, Traffic/legislation & jurisprudence , Accidents, Traffic/prevention & control , Humans , Incidence , Income/statistics & numerical data , Morbidity , Prevalence , Socioeconomic Factors , Sustainable Development/trends , Time FactorsABSTRACT
Microglia as the resident macrophage-like cells in the central nervous system (CNS) play a pivotal role in the innate immune responses of CNS. Understanding the reactions of microglia cells to nanoparticle exposure is important in the exploration of neurobiology of nanoparticles. Here we provide a systemic mapping of microglia and the corresponding pathological changes in olfactory-transport related brain areas of mice with Fe(2)O(3)-nanoparticle intranasal treatment. We showed that intranasal exposure of Fe(2)O(3) nanoparticle could lead to pathological alteration in olfactory bulb, hippocampus and striatum, and caused microglial proliferation, activation and recruitment in these areas, especially in olfactory bulb. Further experiments with BV2 microglial cells showed the exposure to Fe(2)O(3) nanoparticles could induce cells proliferation, phagocytosis and generation of ROS and NO, but did not cause significant release of inflammatory factors, including IL-1ß, IL-6 and TNF-α. Our results indicate that microglial activation may act as an alarm and defense system in the processes of the exogenous nanoparticles invading and storage in brain.
Subject(s)
Ferric Compounds/toxicity , Macrophage Activation/drug effects , Microglia/drug effects , Phagocytosis/drug effects , Animals , Brain/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Corpus Striatum/cytology , Corpus Striatum/drug effects , Cytokines/metabolism , Fluorescent Antibody Technique , Hippocampus/cytology , Hippocampus/drug effects , Iron/pharmacokinetics , Male , Mice , Mice, Inbred ICR , Microglia/immunology , Microglia/ultrastructure , Microscopy, Confocal , Microscopy, Electron, Transmission , Nanoparticles , Nitric Oxide/metabolism , Olfactory Bulb/cytology , Olfactory Bulb/drug effects , Particle Size , Reactive Oxygen Species/metabolism , Spectrometry, X-Ray EmissionABSTRACT
More recently, the correlation between exposure to nanoparticles and cardiovascular diseases is of particular concern in nanotoxicology related fields. Nanoparticle-triggered endothelial dysfunction is hypothesized to be a dominant mechanism in the development of the diseases. To test this hypothesis, iron oxide nanoparticles (Fe2O3 and Fe3O4), as two widely used nanomaterials and the main metallic components in particulate matter, were selected to assess their potential risks on human endothelial system. The direct effects of iron oxide nanoparticles on human aortic endothelial cells (HAECs) and the possible effects mediated by monocyte (U937 cells) phagocytosis and activation were investigated. In the study, HAECs and U937 cells were exposed to 2, 20, 100 µg/mL of 22-nm-Fe2O3 and 43-nm-Fe3O4 particles. Our results indicate that cytoplasmic vacuolation, mitochondrial swelling and cell death were induced in HAEC. A significant increase in nitric oxide (NO) production was induced which coincided with the elevation of nitric oxide synthase (NOS) activity in HAECs. Adhesion of monocytes to the HAECs was significantly enhanced as a consequence of the up-regulation of intracellular cell adhesion molecule-1 (ICAM-1) and interleukin-8 (IL-8) expression, all of which are considered as early steps of atheroscelerosis. Phagocytosis and dissolution of nanoparticles by monocytes were found to simultaneously provoke oxidative stress and mediate severe endothelial toxicity. We conclude that intravascular iron oxide nanoparticles may induce endothelial system inflammation and dysfunction by three ways: (1) nanoparticles may escape from phagocytosis that interact directly with the endothelial monolayer; (2) nanoparticles are phagocytized by monocytes and then dissolved, thus impact the endothelial cells as free iron ions; or (3) nanoparticles are phagocytized by monocytes to provoke oxidative stress responses.
Subject(s)
Atherosclerosis/etiology , Endothelium, Vascular/drug effects , Ferric Compounds/toxicity , Nanoparticles/toxicity , Atherosclerosis/enzymology , Atherosclerosis/metabolism , Cell Adhesion/drug effects , Endothelial Cells , Endothelium, Vascular/enzymology , Endothelium, Vascular/metabolism , Female , Humans , Intercellular Adhesion Molecule-1/metabolism , Interleukin-8/metabolism , Microscopy, Electron, Transmission , Microscopy, Fluorescence , Nitric Oxide Synthase/metabolism , Phagocytosis/drug effects , U937 CellsABSTRACT
With rapid development of nanotechnology, concerns about the possible adverse health effects on human beings by using nanomaterials have been raised. Transparent yellow iron oxide (alpha-FeOOH) nanoparticles have been widely used in paints, plastic, rubber, building materials, papermaking, food products and pharmaceutical industry, thus the potential health implications by the exposure should be considered. The purpose of this study is to assess the cytotoxicity of transparent yellow iron oxide nanoparticles on U251 human glioma cells. The alpha-FeOOH nanoparticles are in clubbed shapes with 9 nm in diameter and 43 nm long. The specific surface area is 115.3 m2/g. After physicochemical characterization of the nanoparticles, U251 cells were exposed to a-FeOOH at the doses of 0, 3.75, 15, 60 and 120 microg/mL. The results showed that the alpha-FeOOH nanoparticles reduced the cell viability and induced necrosis and apoptosis in U251 cells. In addition, nanoparticle exposure significantly increased the levels of superoxide anion and nitric oxide in a dose-dependent fashion in the cells. Our results suggest that exposure to alpha-FeOOH nanoparticles induce significant free radical formation and cytotoxic effects. The large surface area that induced high surface reactivity may play an important role in the cytotoxic effect of alpha-FeOOH nanoparticles.
Subject(s)
Apoptosis/drug effects , Glioma/pathology , Iron Compounds/toxicity , Metal Nanoparticles/toxicity , Minerals/toxicity , Analysis of Variance , Cell Line, Tumor , Cell Survival/drug effects , Humans , Iron Compounds/chemistry , Light , Metal Nanoparticles/chemistry , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Minerals/chemistry , Nitric Oxide/metabolism , Scattering, Radiation , Superoxides/metabolismABSTRACT
Recent epidemiologic researches indicate that exposure to ultrafine particles (nanoparticles) is an independent risk factor for several cardiovascular diseases. The induction of endothelial injuries is hypothesized to be an attractive mechanism involved in these cardiovascular diseases. To investigate this hypothesis, the widely used iron nanomaterials, ferric oxide (Fe2O3) and ferriferrous oxide (Fe3O4) nanoparticles were incubated with human umbilical endothelial cells (ECV304 cells) at different concentrations of 2, 20, 100 microg/mL. The cell viability, the rate of apoptosis, the apoptotic nuclear morphology and the mitochondria membrane potential were measured to estimate the cell necrosis and apoptosis caused by the nanoparticle exposure. The stimulation of superoxide anion (O2*-) and nitric oxide (NO) were examined to evaluate the stress responses of endothelial cells. Our results indicated that both the Fe2O3 and Fe3O4 nanoparticles could generate oxidative stress as well as the significant increase of nitric oxide in ECV304 cells. The loss of mitochondria membrane potential and the apoptotic chromatin condensation in the nucleus were observed as the early signs of apoptosis. It is inferred the stress response might be an important mechanism involving in endothelial cells apoptosis and death, and these injuries in endothelial cells might play a key role in downstream cardiovascular diseases such as atheroscelerosis, hypertension and myocardial infarction (MI).
Subject(s)
Apoptosis/drug effects , Endothelial Cells/drug effects , Magnetite Nanoparticles/toxicity , Oxidative Stress/drug effects , Analysis of Variance , Cell Survival/drug effects , Cells, Cultured , Endothelial Cells/metabolism , Humans , Magnetite Nanoparticles/chemistry , Membrane Potential, Mitochondrial/drug effects , Microscopy, Electron, Transmission , Superoxides/metabolism , Umbilical Cord/cytologyABSTRACT
Urinary chromium speciation analysis can provide available information of the individual exposure levels of Cr(VI) compounds. An analytical method based on ion-pair reversed-phase HPLC combined with ICP-MS to simultaneously determine Cr(III) and Cr(VI) in human urine has been developed for assessing the occupational exposure to chromate. The separation conditions of the method, including the pH value, the concentrations of ion-pair reagent and methanol in the mobile phase were studied. Specially, a high-speed polyetheretherketone (PEEK) column and a typical sample introduction method were employed to avoid the exogenous chromium contamination during the analysis. The separation of Cr(III) and Cr(VI) could be finished within 4min with the detection limits as low as 0.03microgL(-1) at 100microL injections for both of them, providing a convenient method for routine analysis of chromium species. The chromium species in urine of chromate workers were monitored using the developed method. The statistical analysis showed a significant relationship (n=32, p<0.01) between the urinary Cr(VI) and the individual airborne exposure levels, indicating that the urinary Cr(VI) could be used as a convenient and suitable monitor for high level Cr(VI) occupational exposure.
Subject(s)
Chromates/chemistry , Chromatography, High Pressure Liquid/methods , Chromium/chemistry , Chromium/urine , Mass Spectrometry/methods , Occupational Exposure , Adult , Benzophenones , Female , Humans , Ions , Ketones/chemistry , Male , Metals/chemistry , Middle Aged , Polyethylene Glycols/chemistry , Polymers , Semiconductors , Urinalysis/methodsABSTRACT
Exposure to nanoparticles has presented potential risks to human cardiorespiratory systems. Pulmonary retention and extrapulmonary redistribution of inhaled nanoparticles have been considered to be important contributing factors of cardiorespiratory diseases. In the present work, 22-nm (59)Fe(2)O(3) nanoparticles (radioactive isotope (59)Fe-labeled ferric oxide nanoparticles) were intratracheally instilled into the male Sprague-Dawley rats at a dose of 4 mg/rat. Extrapulmonary distribution of (59)Fe(2)O(3) in organs and its metabolism in lung, blood, urine, and feces were measured for 50 days of exposure. Phagocytosis and clearance of agglomerated nano-Fe(2)O(3) by monocytes/macrophages were observed by histopathology and inductively coupled plasma-mass spectrometry examination. Our results showed intratracheal-instilled nano-(59)Fe(2)O(3) could pass through the alveolar-capillary barrier into systemic circulation within 10 min that consisted with one-compartment kinetic model. The nano-(59)Fe(2)O(3) in the lung was distributed to organs rich in mononuclear phagocytes, including liver, spleen, kidney and testicle. The plasma elimination half-life of nano-(59)Fe(2)O(3) was 22.8 days and the lung clearance rate was 3.06 microg/day, indicating the systemic accumulation and lung retention had occurred. The deposited nano-Fe(2)O(3) in interstitial lung was probably contributed by the particles escaping from alveolar macrophages phagocytosis and macrophages clearance function overloading. Our results suggest that the effect of Fe(2)O(3) nanoparticles exposure, even at low concentration, should be assessed because of the potential lung and systemic cumulative toxicity of the nanoparticles.
Subject(s)
Ferric Compounds/pharmacokinetics , Ferric Compounds/toxicity , Lung/metabolism , Nanoparticles/toxicity , Administration, Inhalation , Animals , Area Under Curve , Ferric Compounds/administration & dosage , Half-Life , Humans , Intubation, Intratracheal , Iron Radioisotopes , Lung/pathology , Macrophages/metabolism , Male , Mass Spectrometry , Microscopy, Electron, Transmission , Monocytes/metabolism , Phagocytosis/drug effects , Rats , Rats, Sprague-Dawley , Risk Assessment , U937 CellsABSTRACT
Ferric oxide (Fe(2)O(3)) nanoparticles are of considerable interest for application in nanotechnology related fields. However, as iron being a highly redox-active transition metal, the safety of iron nanomaterials need to be further studied. In this study, the size, dose and time dependent of Fe(2)O(3) nanoparticle on pulmonary and coagulation system have been studied after intratracheal instillation. The Fe(2)O(3) nanoparticles with mean diameters of 22 and 280 nm, respectively, were intratracheally instilled to male Sprague Dawley rats at low (0.8 mg/kgbw) and high (20 mg/kgbw) doses. The toxic effects were monitored in the post-instilled 1, 7 and 30 days. Our results showed that the Fe(2)O(3) nanoparticle exposure could induce oxidative stress in lung. Alveolar macrophage (AM) over-loading of phagocytosed nanoparticle by high dose treatment had occurred, while the non-phagocytosed particles were found entering into alveolar epithelial in day 1 after exposure. Several inflammatory reactions including inflammatory and immune cells increase, clinical pathological changes: follicular hyperplasia, protein effusion, pulmonary capillary vessel hyperaemia and alveolar lipoproteinosis in lung were observed. The sustain burden of particles in AM and epithelium cells has caused lung emphysema and pro-sign of lung fibrosis. At the post-instilled day 30, the typical coagulation parameters, prothrombin time (PT) and activated partial thromboplastin time (APTT) in blood of low dose 22 nm-Fe(2)O(3) treated rats were significantly longer than the controls. We concluded that both of the two-sized Fe(2)O(3) particle intratracheal exposure could induce lung injury. Comparing with the submicron-sized Fe(2)O(3) particle, the nano-sized Fe(2)O(3) particle may increase microvascular permeability and cell lysis in lung epitheliums and disturb blood coagulation parameters significantly.